Hungary reaches deal to buy China's Sinopharm vaccine

File photo

Hungary's government said on Thursday it has reached a deal with China's Sinopharm to buy its coronavirus vaccine.

It's the country's latest move to break away from Brussels as it tries to speed up inoculations to lift curbs on the economy.

Hungary would be the first EU country to accept a Chinese vaccine if approved by Hungarian authorities.

Under European Union rules it would have to give an ultra-fast emergency use approval, rather than waiting for the European drug regulator EMA to give the go-ahead for the Chinese vaccine.

Britain took a similar approach in December before it exited the bloc.

It approved Pfizer Inc's COVID-19 vaccine on December 2, jumping ahead of the rest of the world in the race to begin a mass inoculation programme.

Hungary's nationalist government has sharply criticised the EU for what it said were way too slow vaccine purchases and deliveries that now threatened an economic rebound.

Foreign Minister Peter Szijjarto said in a Facebook post on Thursday that due to the "scandalously" slow vaccine procurements of the European Commission, a fast rollout of vaccines could not happen early this year.

"If we look beyond the EU's borders, we can see that in the US, in Britain and in Israel, people are vaccinated at warp speed," Szijjarto said.

The government also passed a decree on Thursday allowing it to start procurements outside the EU's centralised scheme.

Szijjarto's spokesman told Reuters the approval process for the vaccine developed by Sinopharm's Beijing-based affiliate, Beijing Institute of Biological Products Co., Ltd (BIBP), was already "underway".

Beyond the supply bottlenecks, Hungarians are fairly sceptical about the new vaccines, with just about one in five people definitely planning to get a shot based on a late-December survey by the Central Statistics Office.

Prime Minister Viktor Orban's chief of staff Gergely Gulyas told a briefing on Thursday that vaccine shipments under the EU's programme were arriving too slowly, with weekly shipments of less than 100,000 doses, and Hungary would continue talks with Russia and China about additional vaccine purchases.

"We have practically made an agreement with Sinopharm," Gulyas said. "The first shipment could include up to one million doses."

The timing of the Chinese shipment depends on how fast Hungarian health authorities authorize use of Sinopharm's vaccine, which has been used to immunise some 20 million people, he added.

Gulyas said the second wave of the pandemic has peaked in Hungary and new infections have dropped but restrictions cannot be eased yet.

China approved the shot developed by Sinopharm's BIBP in late December, its first COVID-19 vaccine for general public use.

More from International news

  • Israeli attacks on Gaza killed 60 people in 24 hours

    Israeli occupation forces committed multiple massacres against families in the Gaza Strip over the past 24 hours, resulting in the killing of at least 60 Palestinians and the injury of 162 others, according to medical reports.

  • Trump fires National Security Agency director

    U.S. President Donald Trump fired General Timothy Haugh as director of the National Security Agency on Thursday, according to two officials familiar with the decision, and congressional Democrats denounced the removal of the nonpartisan official from a top security post.

  • Israel steps up Syria strikes, says Turkey aims for 'protectorate'

    Israel stepped up airstrikes on Syria, declaring the attacks a warning to the new rulers in Damascus as it accused their ally Turkey of trying to turn the country into a Turkish protectorate.

  • US sending Israel 20,000 assault rifles that Biden delayed

    The Trump administration moved forward with the sale of more than 20,000 US-made assault rifles to Israel last month, according to a document seen by Reuters, pushing ahead with a sale that the administration of former president Joe Biden had delayed.

News

  • UAE shines in global competitiveness rankings for 2025

    The UAE has maintained its rising performance in the global competitiveness race during the first quarter of 2025 by achieving advanced positions in many relevant international and regional indicators and reports.

  • UAE President marks Senegal independence day

    President His Highness Sheikh Mohamed bin Zayed Al Nahyan has sent a message of congratulations to President Bassirou Diomaye Faye of Senegal on the occasion of his country's Independence Day.

  • UAE expands cancer prevention plan

    The Ministry of Health and Prevention (MoHAP) has reaffirmed its commitment to reducing the incidence of cervical cancer and other HPV-related diseases through a proactive national strategy.